1. research based, people driven LEO Pharma ECENA network visit, June 20, 2006 Lykke Have, Environmental Manager

2. research based, people driven 2 Introducing LEO Pharma  Who we are today  What we value  What we look like  What we generate  What we produce & sell

3. research based, people driven 3 LEO today  Established in 1908 in Denmark  More than 3,000 employees based in 40 countries  Headquarters in Ballerup, Denmark  Offices and affiliates in 25 countries  Areas of expertise are dermatology, coagulation, nephrology, inflammation, and immunology  Products sold in 90 countries  Group profit before tax 337 MEUR (2005)

4. research based, people driven 4 The LEO Vision 2010  LEO is the global, pharmaceutical leader in dermatology based on innovative and efficacious products and associated services  Critical Care is firmly established and the Critical Care portfolio is extended with at least one new brand

5. research based, people driven 5 LEO management structure

6. research based, people driven 6 LEO functions Research & Development  R&D develops drugs and New Chemical Entities (NCE) that alleviate or cure diseases  More than 550 scientists and researchers work in R&D to fulfill these goals  We take the drugs all the way – from organic chemistry, isolation of compounds from microbial and biological material to registration  A substantial part of our research focuses on:  Dermatology  Critical Care  We investigate and manage licensing activities and agreements

7. research based, people driven 7 LEO functions Plants & Manufacturing  More than 900 employees  Five state-of-the-art production plants situated in Denmark, France and Ireland  We are committed to customer service, efficient economic production and specified quality  We comply with all statutory requirements of  GMP  Environmental protection  Safety  Our production areas and equipment are documented, serviced and improved by project teams and a skilled maintenance staff  Active substance production expertise  Advanced organic chemical synthesis  Fermentation  Extraction of tissues  Advanced purification techniques  Synthesis of semi-synthetic penicillins  Finished formulations & preparation production expertise  Pre-filled syringes  Injectors  Vials  Ampoules  Bottle pack eye drops  Tubes  Tablets  Capsules, hard & soft  Solutions - suspensions  Lotions - mixtures  Drops - eardrops  Intertulle

8. research based, people driven 8 LEO functions Sales & Marketing  1,000 employees in S&M worldwide, including approx. 580 sales representatives in Europe and 210 in the rest of the world  We launch, market and sell the products stemming from our research and development  We leverage our strong presence in the European home market into a platform for global expansion  We market our products in 90 countries and have affiliates and sales offices in more than 22 countries  We focus on two key areas:  Dermatology  Critical Care  We monitor and optimise according to market conditions allowing for a flexible approach to marketing

9. research based, people driven 9 Major LEO products DermatologyCritical CareLocal brands Daivobet ® / Dovobet ® / Taclonex ® innohep ® Selexid ® Daivonex ® / Dovonex ® One-Alpha ® Burinex ® Fucidin ® Fucicort ® Fucidin ® H Fucithalmic ®